statistiche ricercatore

Continente	#
NA - Nord America	1.061
EU - Europa	986
AS - Asia	665
SA - Sud America	70
Continente sconosciuto - Info sul continente non disponibili	28
AF - Africa	15
OC - Oceania	5
Totale	2.830

Nazione	#
US - Stati Uniti d'America	1.025
RU - Federazione Russa	359
CN - Cina	269
GB - Regno Unito	212
SG - Singapore	172
IT - Italia	130
DE - Germania	75
VN - Vietnam	55
IE - Irlanda	51
BR - Brasile	47
SE - Svezia	46
FI - Finlandia	39
HK - Hong Kong	39
FR - Francia	36
IN - India	34
KR - Corea	24
CA - Canada	21
BD - Bangladesh	16
IR - Iran	12
AR - Argentina	11
ID - Indonesia	9
NL - Olanda	7
ES - Italia	6
AU - Australia	5
MX - Messico	5
MY - Malesia	5
PL - Polonia	5
CO - Colombia	4
JP - Giappone	4
PK - Pakistan	4
TR - Turchia	4
UA - Ucraina	4
CL - Cile	3
EG - Egitto	3
IQ - Iraq	3
NG - Nigeria	3
UZ - Uzbekistan	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
AZ - Azerbaigian	2
CW - ???statistics.table.value.countryCode.CW???	2
GR - Grecia	2
HR - Croazia	2
LT - Lituania	2
MA - Marocco	2
NI - Nicaragua	2
RO - Romania	2
RS - Serbia	2
VE - Venezuela	2
ZA - Sudafrica	2
BS - Bahamas	1
BW - Botswana	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EC - Ecuador	1
GT - Guatemala	1
HN - Honduras	1
HU - Ungheria	1
IL - Israele	1
JM - Giamaica	1
JO - Giordania	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
MR - Mauritania	1
NP - Nepal	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PT - Portogallo	1
SC - Seychelles	1
SI - Slovenia	1
SN - Senegal	1
SR - Suriname	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
VC - Saint Vincent e Grenadine	1
Totale	2.804

Nome	#
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy	274
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML	271
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy	259
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia	254
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML)	250
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML.	246
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy	244
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions	229
Immunoregulatory properties of bone marrow mesenchymal stromal cell-derived extracellular vesicles	215
Inhibition of Notch signaling enhances chemosensitivity in B cell precursor acute lymphoblastic leukemia	204
Characterization of a new B-ALL cell line with constitutional defect of the Notch signaling pathway	194
Assessment of haematopoietic progenitor cell counting with the Sysmex® XN-1000 to guide timing of apheresis of peripheral blood stem cells.	190
Totale	2.830

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	58	0	0	0	0	8	3	2	4	0	4	7	30
2022/2023	261	12	34	20	38	22	71	1	14	39	3	5	2
2023/2024	175	6	12	7	15	23	45	0	12	1	12	40	2
2024/2025	315	15	16	22	62	10	19	1	12	52	11	37	58
2025/2026	1.122	64	53	90	196	306	61	102	46	81	79	20	24
2026/2027	223	9	26	45	130	13	0	0	0	0	0	0	0
Totale													2.830

CATALOGO DEI PRODOTTI DELLA RICERCA